Post-Approval Safety Monitoring Program to Assess the Safety Profile of GARDASIL in China Usual Practice
This is a post-Approval Safety Monitoring Program to assess the safety profile of GARDASIL in china usual practice.
Cervical Cancer
BIOLOGICAL: HPV 4
Evaluate the Rate of Adverse reactions of GARDASIL in China usual practice, Adverse reactions associated with vaccine will be observed in females Aged 20-45 Years after vaccination. Solicited local adverse events include Pain, Redness, Swelling, Induration, Rash, Pruritus at injection site. solicited general adverse events include Fever, Nausea, Vomiting, Diarrhea, Decreased appetite, Be agitated (irritability, abnormal crying), fatigue, allergy, 24 months|Number of participants with adverse events following any dose of vaccine, Number of participants with adverse events following any dose of vaccine, within 30 days after each dose
This is a post-Approval Safety Monitoring Program to assess the safety profile of GARDASIL in china usual practice.